Mitochondria Profoundly Influence Apolipoprotein E Biology.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2023
Historique:
medline: 28 3 2023
pubmed: 14 2 2023
entrez: 13 2 2023
Statut: ppublish

Résumé

Mitochondria can trigger Alzheimer's disease (AD)-associated molecular phenomena, but how mitochondria impact apolipoprotein E (APOE; apoE) is not well known. Consider whether and how mitochondrial biology influences APOE and apoE biology. We measured APOE expression in human SH-SY5Y neuronal cells with different forms of mitochondrial dysfunction including total, chronic mitochondrial DNA (mtDNA) depletion (ρ0 cells); acute, partial mtDNA depletion; and toxin-induced mitochondrial dysfunction. We further assessed intracellular and secreted apoE protein levels in the ρ0 cells and interrogated the impact of transcription factors and stress signaling pathways known to influence APOE expression. SH-SY5Y ρ0 cells exhibited a 65-fold increase in APOE mRNA, an 8-fold increase in secreted apoE protein, and increased intracellular apoE protein. Other models of primary mitochondrial dysfunction including partial mtDNA-depletion, toxin-induced respiratory chain inhibition, and chemical-induced manipulations of the mitochondrial membrane potential similarly increased SH-SY5Y cell APOE mRNA. We explored potential mediators and found in the ρ0 cells knock-down of the C/EBPα and NFE2L2 (Nrf2) transcription factors reduced APOE mRNA. The activity of two mitogen-activated protein kinases, JNK and ERK, also strongly influenced ρ0 cell APOE mRNA levels. Primary mitochondrial dysfunction either directly or indirectly activates APOE expression in a neuronal cell model by altering transcription factors and stress signaling pathways. These studies demonstrate mitochondrial biology can influence the biology of the APOE gene and apoE protein, which are implicated in AD.

Sections du résumé

BACKGROUND
Mitochondria can trigger Alzheimer's disease (AD)-associated molecular phenomena, but how mitochondria impact apolipoprotein E (APOE; apoE) is not well known.
OBJECTIVE
Consider whether and how mitochondrial biology influences APOE and apoE biology.
METHODS
We measured APOE expression in human SH-SY5Y neuronal cells with different forms of mitochondrial dysfunction including total, chronic mitochondrial DNA (mtDNA) depletion (ρ0 cells); acute, partial mtDNA depletion; and toxin-induced mitochondrial dysfunction. We further assessed intracellular and secreted apoE protein levels in the ρ0 cells and interrogated the impact of transcription factors and stress signaling pathways known to influence APOE expression.
RESULTS
SH-SY5Y ρ0 cells exhibited a 65-fold increase in APOE mRNA, an 8-fold increase in secreted apoE protein, and increased intracellular apoE protein. Other models of primary mitochondrial dysfunction including partial mtDNA-depletion, toxin-induced respiratory chain inhibition, and chemical-induced manipulations of the mitochondrial membrane potential similarly increased SH-SY5Y cell APOE mRNA. We explored potential mediators and found in the ρ0 cells knock-down of the C/EBPα and NFE2L2 (Nrf2) transcription factors reduced APOE mRNA. The activity of two mitogen-activated protein kinases, JNK and ERK, also strongly influenced ρ0 cell APOE mRNA levels.
CONCLUSION
Primary mitochondrial dysfunction either directly or indirectly activates APOE expression in a neuronal cell model by altering transcription factors and stress signaling pathways. These studies demonstrate mitochondrial biology can influence the biology of the APOE gene and apoE protein, which are implicated in AD.

Identifiants

pubmed: 36776072
pii: JAD221177
doi: 10.3233/JAD-221177
doi:

Substances chimiques

DNA, Mitochondrial 0
Apolipoproteins E 0
Transcription Factors 0
RNA, Messenger 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

591-604

Subventions

Organisme : NIA NIH HHS
ID : P30 AG072973
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG061194
Pays : United States

Auteurs

Alexander P Gabrielli (AP)

University of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.

Ian Weidling (I)

University of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.

Amol Ranjan (A)

University of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.

Xiaowan Wang (X)

University of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.

Lesya Novikova (L)

University of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.

Subir Roy Chowdhury (SR)

University of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.

Blaise Menta (B)

University of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.
Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA.

Alexandra Berkowicz (A)

University of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.
Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA.

Heather M Wilkins (HM)

University of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.
Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA.
Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.

Kenneth R Peterson (KR)

University of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.
Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.

Russell H Swerdlow (RH)

University of Kansas Alzheimer's Disease Research Center, Kansas City, KS, USA.
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.
Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA.
Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH